Earlier quoted context omitted.
> Cost effectiveness... well ipillimumab costs 100k a year for 4 doses, and nivolumab is probably going to cost another 100k at least on top of that, and is generally continued indefinitely, and the medication to turn off overly vigorous immune responses can also be expensive... I cannot imagine a chemical process to create those drugs that justifies the prices mentioned. Is the price at least subsidising the costs o…
Drug R+D plus approval processes are very expensive both in time (>10 years) and money (>2 American billions) [1] [1] http://csdd.tufts.edu/news/complete_story/pr_tufts_csdd_2014...
Cure for cancer one step closer after 'spectacular' breakthrough
51–60 of 74 posts
Re: Cure for cancer one step closer after 'spectacular' breakthrough
#52Earlier quoted context omitted.
My hunch is, the more greedy the patent holders are, the more likely, and the faster replacement cures will come to market. And if that day comes, I certainly hope one of those replacement cures puts the greedy ones out of business. On a darker note, I think your second comment speaks volumes about the kind of human being you are. I hope one day, years from now, you will take the time to come back to this comment and…
It's not really about greed, this drug really and truly is extremely expensive to make.
The parent comment I was replying to seems to imply it would be a good / welcome idea for patent / stake-holders to be greedy and make billions in profits.
Re: Cure for cancer one step closer after 'spectacular' breakthrough
#53Earlier quoted context omitted.
> Cost effectiveness... well ipillimumab costs 100k a year for 4 doses, and nivolumab is probably going to cost another 100k at least on top of that, and is generally continued indefinitely, and the medication to turn off overly vigorous immune responses can also be expensive... I cannot imagine a chemical process to create those drugs that justifies the prices mentioned. Is the price at least subsidising the costs o…
Drug R+D plus approval processes are very expensive both in time (>10 years) and money (>2 American billions) [1] [1] http://csdd.tufts.edu/news/complete_story/pr_tufts_csdd_2014...
I would bet if these processes were carried out "transparently" we would find alot of waste and inefficiencies.
I get the feeling things will change once Silicon Valley finally decides to get more invested in the pharmaceutical industry.
Re: Cure for cancer one step closer after 'spectacular' breakthrough
#54Earlier quoted context omitted.
> Cost effectiveness... well ipillimumab costs 100k a year for 4 doses, and nivolumab is probably going to cost another 100k at least on top of that, and is generally continued indefinitely, and the medication to turn off overly vigorous immune responses can also be expensive... I cannot imagine a chemical process to create those drugs that justifies the prices mentioned. Is the price at least subsidising the costs o…
> I cannot imagine a chemical process to create those drugs that justifies the prices mentioned. It's a Monoclonal antibody, they are currently by far the most expensive drugs ever made. They are very difficult to make, and almost impossible to make in bulk. It's not a chemical process, it's a biological one. Unfortunately monoclonal antibodies are also some of the most promising drugs currently available. They can d…
Wikipedia[1] is full of jargon, but one caption says "Monoclonal antibodies can be grown in unlimited quantities in the bottles shown in this picture". So the process at least looks scalable. What materials/constraints can possibly cost $25k per dose?
[1] http://en.wikipedia.org/wiki/Monoclonal_antibody#Production
Re: Cure for cancer one step closer after 'spectacular' breakthrough
#55Earlier quoted context omitted.
> Cost effectiveness... well ipillimumab costs 100k a year for 4 doses, and nivolumab is probably going to cost another 100k at least on top of that, and is generally continued indefinitely, and the medication to turn off overly vigorous immune responses can also be expensive... I cannot imagine a chemical process to create those drugs that justifies the prices mentioned. Is the price at least subsidising the costs o…
Actual c cost to produce is probably in the 50k range (still a huge markup). Its a biologic - There is lots of batch to batch variation and some batches have to be chucked if they don't meet QC.
Re: Cure for cancer one step closer after 'spectacular' breakthrough
#56Earlier quoted context omitted.
> I cannot imagine a chemical process to create those drugs that justifies the prices mentioned. It's a Monoclonal antibody, they are currently by far the most expensive drugs ever made. They are very difficult to make, and almost impossible to make in bulk. It's not a chemical process, it's a biological one. Unfortunately monoclonal antibodies are also some of the most promising drugs currently available. They can d…
Could you give a brief explanation (in layman's terms) of why they are so difficult/expensive to make? Wikipedia[1] is full of jargon, but one caption says "Monoclonal antibodies can be grown in unlimited quantities in the bottles shown in this picture". So the process at least looks scalable. What materials/constraints can possibly cost $25k per dose? [1] http://en.wikipedia.org/wiki/Monoclonal_antibody#Production
Re: Cure for cancer one step closer after 'spectacular' breakthrough
#57Earlier quoted context omitted.
It's not really about greed, this drug really and truly is extremely expensive to make.
I agree, but with one caveat. It's only about greed if the patent / stake-holders make it about greed. The parent comment I was replying to seems to imply it would be a good / welcome idea for patent / stake-holders to be greedy and make billions in profits.
same for something that is a product that takes billions to develop and get approved, plus saves actual lives? how DARE I!?
resources in a capitalist society get allocated by rewards on efforts. i want the best resources working this, hence the incentives need to be spectacular. competing against HFT and other hot areas here.
Re: Cure for cancer one step closer after 'spectacular' breakthrough
#58Earlier quoted context omitted.
Dear Downvoter, Am I wrong?
Your tone is misplaced. I'm an oncologist, and with no conflicts of interest I can assure you these drugs are a bona fide breakthrough.
Re: Cure for cancer one step closer after 'spectacular' breakthrough
#59Earlier quoted context omitted.
I agree, but with one caveat. It's only about greed if the patent / stake-holders make it about greed. The parent comment I was replying to seems to imply it would be a good / welcome idea for patent / stake-holders to be greedy and make billions in profits.
so billions for FB/Instagram/CocaCola/Tesla - all justified. same for something that is a product that takes billions to develop and get approved, plus saves actual lives? how DARE I!? resources in a capitalist society get allocated by rewards on efforts. i want the best resources working this, hence the incentives need to be spectacular. competing against HFT and other hot areas here.
If I am so blessed to be in a position that I have invented a cure for cancer, I am giving it away. At the most I want to break even. If I make a single penny from the invention I'm donating it to charity.
If you're motivated by profit, you should not be in the business of saving lives.
Re: Cure for cancer one step closer after 'spectacular' breakthrough
#60Some context. One of the drugs in the combination Ipillimumab has been used for a while now, and seems to produce long term survival in about 10% of patients with incurable melanoma. Some of these patients seem effectively cured, having survived 7 years or more without any other treatment. It seems likely that combination therapy will produce a better rate of effective cure. This is a pretty big deal, because advance…
Amazing stuff.